CELU CELULARITY INC

NASDAQ
$1.38

CELULARITY INC (CELU) is expected to report earnings on December 29, 2026, after the market close.

CELULARITY INC Reported Earnings
Tuesday, September 29, 2026 · 12:00 AM ET
Earnings Date
Dec 29
Tuesday · 12:00 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About CELULARITY INC

Celularity Inc. is a clinical stage biotechnology company. It involved in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified NK cells, genetically-modified NK cells, T cells engineered with a CAR and mesenchymal-like adherent stromal cells targeting indications across cancer, infectious and degenerative diseases. Celularity Inc., formerly known as GX Acquisition Corp., is based in NEW YORK.

Sector

Healthcare

Charts powered in part by Lightweight Charts™ by TradingView.